Evidence is building that GLP-1 drugs may slow aging in mammals
Louis comments that evidence is accumulating that GLP-1 agonists slow aging in mammals, in line with calorie restriction extending lifespan in animals. The shared investigation covers the semaglutide 3.1-year biological age claim and a 2026 Nature study of longer-lived old female mice.

